- Free from Publisher P Phillips, J Karrasch, R Scott, D Wilson, R … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—The intention-to-treat analysis from baseline to week 24 (81 patients
for HbA 1c and 82 for fasting blood glucose) showed statistically significant
differences between acarbose and placebo treatment in HbA 1c (1.02%; 95% CI ... Cited by 26 - Related articles - BL Direct - All 10 versions
S Halimi, MA Le Berre, V Grange - Diabetes research and clinical practice, 2000 - Elsevier This 6-month, double-blind, placebo-controlled, randomised, parallel-group study
investigated the potential of acarbose add-on therapy for improving the
glycaemic control of overweight patients with Type 2 diabetes and was ... Cited by 23 - Related articles - All 7 versions
M Feinglos, G Dailey, W Cefalu, K Osei, J … - Diabetes research and clinical practice, 2005 - Elsevier The addition of glipizide GITS to metformin gave significantly greater
improvements in mean A 1c and FPG from baseline to endpoint than placebo
addition (p < 0.0002). Significantly more patients in the glipizide GITS ... Cited by 12 - Related articles - All 8 versions
G Charpentier, F Fleury, M Kabir, L Vaur, S … - Diabetic Medicine, 2001 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 53 - Related articles - BL Direct - All 6 versions
- Free from Publisher J Rosenstock, A Brown, J Fischer, A Jain, T … - Diabetes Care, 1998 - Am Diabetes Assoc T he aim of all strategies for the meta- bolic control of diabetes is to achieve
no rmoglycemia. In patients with type 2 diabetes with milder elevations in
fasting plasma glucose, aninitial attempt to contro l blood glucose is ... Cited by 62 - Related articles - BL Direct - All 6 versions
B Willms, D Ruge - Diabetic Medicine, 1999 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 42 - Related articles - BL Direct - All 5 versions
L Blonde, J Rosenstock, AD Mooradian, BA … - Diabetes Obesity and Metabolism, 2002 - interscience.wiley.com Methods:In this 16-week, randomized, double-blind, parallel group study, 639
patients with inadequate glycaemic control on at least half-maximal dose of
sulphonylurea were randomly assigned to: glyburide 10 mg bid (n = 164); ... Cited by 39 - Related articles - BL Direct - All 5 versions
B Costa, C Pinol, D Acarbose Research … - Diabetes research and clinical practice, 1997 - Elsevier 34 В. Costa et al. /Diabetes Research and Clinical Practice 38 (1997) 33-40
Keywords: Diabetes mellitus; Acarbose; Secondary sulfonylurea failure;
Pharmacotherapy 1. Introduction The natural history of ... Cited by 21 - Related articles - All 5 versions
- ►diabetesjournals.org V Fonseca, G Grunberger, S Gupta, S Shen, … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—In placebo-treated patients, HbA 1c did not change (Δ = 0.0 ± 0.1%).
In patients randomized to nateglinide, HbA 1c decreased from 8.3 to 7.5% (Δ =
−0.8 ± 0.1%, P < 0.0001 vs. placebo). Target HbA 1c (<7.0%) was achieved ... Cited by 35 - Related articles - BL Direct - All 9 versions
M Marre, H Howlett, P Lehert, T Allavoine - Diabetic Medicine, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 44 - Related articles - BL Direct - All 4 versions
